{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T00:49:24Z","timestamp":1789778964035,"version":"4.0.1"},"reference-count":136,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","diabetesresearchclinicalpractice.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Diabetes Research and Clinical Practice"],"published-print":{"date-parts":[[2021,8]]},"DOI":"10.1016\/j.diabres.2021.108959","type":"journal-article","created":{"date-parts":[[2021,7,16]],"date-time":"2021-07-16T23:43:22Z","timestamp":1626479002000},"page":"108959","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":67,"special_numbering":"C","title":["Does a strict glycemic control during acute coronary syndrome play a cardioprotective effect? Pathophysiology and clinical evidence"],"prefix":"10.1016","volume":"178","author":[{"given":"Alfredo","family":"Caturano","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raffaele","family":"Galiero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pia Clara","family":"Pafundi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arturo","family":"Cesaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erica","family":"Vetrano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Palmiero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luca","family":"Rinaldi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teresa","family":"Salvatore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raffaele","family":"Marfella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Celestino","family":"Sardu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabetta","family":"Moscarella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Felice","family":"Gragnano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Calabr\u00f2","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ferdinando Carlo","family":"Sasso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9","key":"10.1016\/j.diabres.2021.108959_b0005","doi-asserted-by":"crossref","DOI":"10.1161\/CIR.0000000000000757","article-title":"Heart disease and stroke statistics-2020 update: A report from the american heart association","volume":"141","author":"Virani","year":"2020","journal-title":"Circulation"},{"key":"10.1016\/j.diabres.2021.108959_b0010","doi-asserted-by":"crossref","unstructured":"Pearson-Stuttard J, Kypridemos C, Collins B, et al. Estimating the health and economic effects of the proposed US Food and Drug Administration voluntary sodium reformulation: Microsimulation cost-effectiveness analysis. PLoS Med. 2018;15(4):e1002551. Published 2018 Apr 10. doi:10.1371\/journal.pmed.1002551.","DOI":"10.1371\/journal.pmed.1002551"},{"issue":"42","key":"10.1016\/j.diabres.2021.108959_b0015","doi-asserted-by":"crossref","first-page":"3232","DOI":"10.1093\/eurheartj\/ehw334","article-title":"Cardiovascular disease in Europe: epidemiological update 2016","volume":"37","author":"Townsend","year":"2016","journal-title":"Eur Heart J"},{"issue":"4","key":"10.1016\/j.diabres.2021.108959_b0020","article-title":"Heart disease and stroke statistics-2016 update: a report from the american heart association","volume":"133","author":"Mozaffarian","year":"2016","journal-title":"Circulation"},{"issue":"4","key":"10.1016\/j.diabres.2021.108959_b0025","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1177\/2047487312444371","article-title":"Fasting glucose, HbA1c, or oral glucose tolerance testing for the detection of glucose abnormalities in patients with acute coronary syndromes","volume":"20","author":"Hage","year":"2013","journal-title":"Eur J Prev Cardiol"},{"key":"10.1016\/j.diabres.2021.108959_b0030","doi-asserted-by":"crossref","unstructured":"Bellis, A., Mauro, C., Barbato, E., Ceriello, A., Cittadini, A., Morisco, C. Stress-Induced Hyperglycaemia in Non-Diabetic Patients with Acute Coronary Syndrome: From Molecular Mechanisms to New Therapeutic Perspectives. Int. J. Mol. Sci. 2021;22(2):775. Published 2021 Jan 14. doi:10.3390\/ijms22020775.","DOI":"10.3390\/ijms22020775"},{"issue":"11","key":"10.1016\/j.diabres.2021.108959_b0035","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1016\/j.hlc.2015.04.171","article-title":"Admission glycaemia and acute insulin resistance in heart failure complicating acute coronary syndrome","volume":"24","author":"Lazzeri","year":"2015","journal-title":"Heart, Lung Circ"},{"issue":"4","key":"10.1016\/j.diabres.2021.108959_b0040","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1210\/jc.2010-1382","article-title":"Innate immune activity in plaque of patients with untreated and L-thyroxine-treated subclinical hypothyroidism","volume":"96","author":"Marfella","year":"2011","journal-title":"J Clin Endocrin Metab"},{"issue":"3","key":"10.1016\/j.diabres.2021.108959_b0045","doi-asserted-by":"crossref","first-page":"E13","DOI":"10.1016\/j.ahj.2004.01.029","article-title":"Acute effects of beta-endorphin on cardiovascular function in patients with mild to moderate chronic heart failure","volume":"148","author":"Cozzolino","year":"2004","journal-title":"Am Heart J"},{"issue":"2","key":"10.1016\/j.diabres.2021.108959_b0050","first-page":"713","article-title":"The involvement of the opioid system in human obesity: A study in normal weight relatives of obese people","volume":"81","author":"Cozzolino","year":"1996","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"11","key":"10.1016\/j.diabres.2021.108959_b0055","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1016\/S0026-0495(99)90141-5","article-title":"Cochlear dysfunction in type 2 diabetes: a complication independent of neuropathy and acute hyperglycemia","volume":"48","author":"Sasso","year":"1999","journal-title":"Metab Clin Exp"},{"issue":"2","key":"10.1016\/j.diabres.2021.108959_b0060","doi-asserted-by":"crossref","first-page":"e000132","DOI":"10.1136\/esmoopen-2016-000132","article-title":"Results of the safety run-in part of the METAL (METformin in Advanced Lung cancer) study: a multicentre, open-label phase I-II study of metformin with erlotinib in second-line therapy of patients with stage IV non-small-cell lung cancer","volume":"2","author":"Morgillo","year":"2017","journal-title":"ESMO Open"},{"key":"10.1016\/j.diabres.2021.108959_b0065","doi-asserted-by":"crossref","DOI":"10.1002\/dmrr.3113","article-title":"Telemedicine for screening diabetic retinopathy: The NO BLIND Italian multicenter study","volume":"35","author":"Sasso","year":"2019","journal-title":"Diabetes Metab Res Rev"},{"issue":"5","key":"10.1016\/j.diabres.2021.108959_b0070","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1016\/j.ajem.2017.01.018","article-title":"Seasonal variations of hyponatremia in the emergency department: age-related changes","volume":"35","author":"Giordano","year":"2017","journal-title":"Am J Emerg Med"},{"issue":"2","key":"10.1016\/j.diabres.2021.108959_b0075","doi-asserted-by":"crossref","first-page":"270","DOI":"10.3390\/antiox10020270","article-title":"Mechanisms of non-alcoholic fatty liver disease in the metabolic syndrome a narrative review","volume":"10","author":"Rinaldi","year":"2021","journal-title":"Antioxidants (Basel)"},{"key":"10.1016\/j.diabres.2021.108959_b0080","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2020\/9036847","article-title":"The importance of telemedicine during COVID-19 pandemic: a focus on diabetic retinopathy","volume":"2020","author":"Galiero","year":"2020","journal-title":"J Diabetes Res."},{"key":"10.1016\/j.diabres.2021.108959_b0085","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.diabres.2019.03.028","article-title":"NO BLIND study group. High HDL cholesterol: a risk factor for diabetic retinopathy? findings from NO BLIND study","volume":"150","author":"Sasso","year":"2019","journal-title":"Diabetes Res Clin Pract"},{"issue":"9","key":"10.1016\/j.diabres.2021.108959_b0090","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1016\/j.numecd.2019.05.065","article-title":"NO BLIND Study Group. Relationship between albuminuric CKD and diabetic retinopathy in a real-world setting of type 2 diabetes: Findings from No blind study","volume":"29","author":"Sasso","year":"2019","journal-title":"Nutr Metab Cardiovasc Dis"},{"issue":"9206","key":"10.1016\/j.diabres.2021.108959_b0095","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1016\/S0140-6736(99)08415-9","article-title":"Stress hyperglycaemia and increased risk of death after myocardial infarction in patients with and without diabetes: a systematic overview","volume":"355","author":"Capes","year":"2000","journal-title":"Lancet (London, England)"},{"issue":"13","key":"10.1016\/j.diabres.2021.108959_b0100","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1093\/eurheartj\/ehi230","article-title":"Association between hyper- and hypoglycaemia and 2 year all-cause mortality risk in diabetic patients with acute coronary events","volume":"26","author":"Svensson","year":"2005","journal-title":"Eur Heart J"},{"issue":"8","key":"10.1016\/j.diabres.2021.108959_b0105","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1161\/CIRCULATIONAHA.107.740498","article-title":"Glucometrics in patients hospitalized with acute myocardial infarction: defining the optimal outcomes-based measure of risk","volume":"117","author":"Kosiborod","year":"2008","journal-title":"Circulation"},{"issue":"12","key":"10.1016\/j.diabres.2021.108959_b0110","doi-asserted-by":"crossref","first-page":"1610","DOI":"10.1161\/CIRCULATIONAHA.107.188629","article-title":"Hyperglycemia and acute coronary syndrome: a scientific statement from the american heart association diabetes committee of the council on nutrition, physical activity, and metabolism","volume":"117","author":"Deedwania","year":"2008","journal-title":"Circulation"},{"issue":"11","key":"10.1016\/j.diabres.2021.108959_b0115","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1093\/eurheartj\/ehi884","article-title":"Prognostic significance of the change in glucose level in the first 24 h after acute myocardial infarction: results from the CARDINAL study","volume":"27","author":"Goyal","year":"2006","journal-title":"Eur Heart J"},{"key":"10.1016\/j.diabres.2021.108959_b0120","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2015\/341583","article-title":"Relevance of sympathetic nervous system activation in obesity and metabolic syndrome","volume":"2015","author":"Thorp","year":"2015","journal-title":"J Diabetes Res"},{"issue":"17","key":"10.1016\/j.diabres.2021.108959_b0125","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1161\/01.CIR.97.17.1695","article-title":"Acute hyperglycemia attenuates endothelium-dependent vasodilation in humans in vivo","volume":"97","author":"Williams","year":"1998","journal-title":"Circulation"},{"issue":"Supplement 1","key":"10.1016\/j.diabres.2021.108959_b0130","doi-asserted-by":"crossref","first-page":"S130","DOI":"10.2337\/diabetes.51.2007.S130","article-title":"Effect of acute hyperglycemia on insulin secretion in humans","volume":"51","author":"Toschi","year":"2002","journal-title":"Diabetes"},{"issue":"1","key":"10.1016\/j.diabres.2021.108959_b0135","doi-asserted-by":"crossref","first-page":"3","DOI":"10.3390\/biomedicines9010003","article-title":"Can metformin exert as an active drug on endothelial dysfunction in diabetic subjects?","volume":"9","author":"Salvatore","year":"2020","journal-title":"Biomedicines"},{"key":"10.1016\/j.diabres.2021.108959_b0140","doi-asserted-by":"crossref","unstructured":"Minutolo, R., Gabbai, F. B., Provenzano, M., Chiodini, P., Borrelli, S., Garofalo, C., Sasso, F. C., Santoro, D., Bellizzi, V., Conte, G., & De Nicola, L. (2018). Cardiorenal prognosis by residual proteinuria level in diabetic chronic kidney disease: pooled analysis of four cohort studies. Nephrol. Dial. Transplant. 33(11), 1942\u20131949. https:\/\/doi.org\/10.1093\/ndt\/gfy032.","DOI":"10.1093\/ndt\/gfy032"},{"key":"10.1016\/j.diabres.2021.108959_b0145","doi-asserted-by":"crossref","unstructured":"Meza, C.A., La Favor, J.D., Kim, D.H., Hickner, R.C. Endothelial Dysfunction: Is There a Hyperglycemia-Induced Imbalance of NOX and NOS?. Int. J. Mol. Sci. 2019;20(15):3775. Published 2019 Aug 2. doi:10.3390\/ijms20153775.","DOI":"10.3390\/ijms20153775"},{"issue":"4","key":"10.1016\/j.diabres.2021.108959_b0150","first-page":"H1626","article-title":"Expression of phagocyte NADPH oxidase components in human endothelial cells","volume":"271","author":"Jones","year":"1996","journal-title":"Am J Physiol"},{"issue":"3","key":"10.1016\/j.diabres.2021.108959_b0155","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1164\/ajrccm.165.3.2103028","article-title":"Molecular characterization of a superoxide-generating NAD(P)H oxidase in the ventilatory muscles","volume":"165","author":"Javeshghani","year":"2002","journal-title":"Am J Respir Crit Care Med"},{"issue":"9","key":"10.1016\/j.diabres.2021.108959_b0160","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1111\/cns.12131","article-title":"Resveratrol protects vascular endothelial cells from high glucose-induced apoptosis through inhibition of NADPH oxidase activation-driven oxidative stress","volume":"19","author":"Chen","year":"2013","journal-title":"CNS Neurosci Ther"},{"issue":"4","key":"10.1016\/j.diabres.2021.108959_b0165","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1172\/JCI5971","article-title":"Characterization of selective resistance to insulin signaling in the vasculature of obese Zucker (fa\/fa) rats","volume":"104","author":"Jiang","year":"1999","journal-title":"J Clin Invest"},{"issue":"3","key":"10.1016\/j.diabres.2021.108959_b0170","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1172\/JCI7535","article-title":"Insulin resistance differentially affects the PI 3-kinase- and MAP kinase-mediated signaling in human muscle","volume":"105","author":"Cusi","year":"2000","journal-title":"J Clin Invest"},{"key":"10.1016\/j.diabres.2021.108959_b0175","doi-asserted-by":"crossref","unstructured":"Goldstein, B.J., Mahadev, K., Wu, X., Zhu, L., Motoshima, H. Role of insulin-induced reactive oxygen species in the insulin signaling pathway. Antioxid Redox Signal. 2005 Jul-Aug; 7(7-8):1021\u201331.","DOI":"10.1089\/ars.2005.7.1021"},{"issue":"6","key":"10.1016\/j.diabres.2021.108959_b0180","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1161\/ATVBAHA.110.219238","article-title":"Endothelial Nox4 NADPH oxidase enhances vasodilatation and reduces blood pressure in vivo","volume":"31","author":"Ray","year":"2011","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"9","key":"10.1016\/j.diabres.2021.108959_b0185","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1016\/j.freeradbiomed.2008.08.013","article-title":"Distinct roles of Nox1 and Nox4 in basal and angiotensin II-stimulated superoxide and hydrogen peroxide production","volume":"45","author":"Dikalov","year":"2008","journal-title":"Free Radic Biol Med"},{"issue":"31","key":"10.1016\/j.diabres.2021.108959_b0190","doi-asserted-by":"crossref","first-page":"5111","DOI":"10.1021\/bi500331y","article-title":"Nox4: a hydrogen peroxide-generating oxygen sensor","volume":"53","author":"Nisimoto","year":"2014","journal-title":"Biochemistry"},{"issue":"6","key":"10.1016\/j.diabres.2021.108959_b0195","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1111\/j.1463-1326.2006.00655.x","article-title":"Diabetes-associated macrovasculopathy: pathophysiology and pathogenesis","volume":"9","author":"Rahman","year":"2007","journal-title":"Diabetes Obes Metab"},{"issue":"2","key":"10.1016\/j.diabres.2021.108959_b0200","doi-asserted-by":"crossref","first-page":"553","DOI":"10.2337\/diacare.27.2.553","article-title":"Management of diabetes and hyperglycemia in hospitals","volume":"27","author":"Clement","year":"2004","journal-title":"Diabetes Care"},{"issue":"2","key":"10.1016\/j.diabres.2021.108959_b0205","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1111\/liv.14274","article-title":"Liver fibrosis by FibroScan\u00ae independently of established cardiovascular risk parameters associates with macrovascular and microvascular complications in patients with type 2 diabetes","volume":"40","author":"Lombardi","year":"2020","journal-title":"Liver international: official journal of the International Association for the Study of the Liver"},{"key":"10.1016\/j.diabres.2021.108959_b0210","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.atherosclerosis.2020.01.010","article-title":"Impact of hepatitis C virus clearance by direct-acting antiviral treatment on the incidence of major cardiovascular events: A prospective multicentre study","volume":"296","author":"Adinolfi","year":"2020","journal-title":"Atherosclerosis"},{"issue":"2","key":"10.1016\/j.diabres.2021.108959_b0215","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/j.cgh.2018.11.011","article-title":"FibroScan Identifies Patients With Nonalcoholic Fatty Liver Disease and Cardiovascular Damage","volume":"18","author":"Lombardi","year":"2020","journal-title":"Clinical Gastroenterology and Hepatology : the official clinical practice journal of the American Gastroenterological Association"},{"issue":"281","key":"10.1016\/j.diabres.2021.108959_b0220","doi-asserted-by":"crossref","first-page":"H2097","DOI":"10.1152\/ajpheart.2001.281.5.H2097","article-title":"Hyperglycemia reduces coronary collateral blood flow through a nitric oxide-mediated mechanism","volume":"2001","author":"Kersten","year":"2001","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"4","key":"10.1016\/j.diabres.2021.108959_b0225","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.2337\/diabetes.51.4.1076","article-title":"Acute hyperglycemia induces nitrotyrosine formation and apoptosis in perfused heart from rat","volume":"51","author":"Ceriello","year":"2002","journal-title":"Diabetes"},{"issue":"1","key":"10.1016\/j.diabres.2021.108959_b0230","doi-asserted-by":"crossref","DOI":"10.1186\/s12872-016-0199-1","article-title":"In-hospital free fatty acids levels predict the severity of myocardial ischemia of acute coronary syndrome","volume":"16","author":"Ma","year":"2016","journal-title":"BMC Cardiovasc Disord"},{"issue":"4","key":"10.1016\/j.diabres.2021.108959_b0235","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1515\/CCLM.2008.118","article-title":"Free fatty acids as a cardiovascular risk factor","volume":"46","author":"Pilz","year":"2008","journal-title":"Clin Chem Lab Med"},{"issue":"23","key":"10.1016\/j.diabres.2021.108959_b0240","doi-asserted-by":"crossref","first-page":"1883","DOI":"10.1136\/hrt.2010.205534","article-title":"Control of free fatty acids during acute myocardial ischaemia","volume":"96","author":"Oliver","year":"2010","journal-title":"Heart"},{"key":"10.1016\/j.diabres.2021.108959_b0245","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2018\/3106056","article-title":"Role of tight glycemic control during acute coronary syndrome on CV outcome in type 2 diabetes","volume":"2018","author":"Sasso","year":"2018","journal-title":"J Diabetes Res"},{"issue":"17","key":"10.1016\/j.diabres.2021.108959_b0250","doi-asserted-by":"crossref","first-page":"4481","DOI":"10.1113\/JP278332","article-title":"A novel form of glycolytic metabolism-dependent cardioprotection revealed by PKC\u03b1 and \u03b2 inhibition","volume":"597","author":"Brennan","year":"2019","journal-title":"J Physiol"},{"issue":"1","key":"10.1016\/j.diabres.2021.108959_b0255","doi-asserted-by":"crossref","DOI":"10.1186\/s12933-019-0826-0","article-title":"Adiponectin and insulin resistance are related to restenosis and overall new PCI in subjects with normal glucose tolerance: the prospective AIRE Study","volume":"18","author":"Sasso","year":"2019","journal-title":"Cardiovasc Diabetology"},{"issue":"4","key":"10.1016\/j.diabres.2021.108959_b0260","doi-asserted-by":"crossref","first-page":"271","DOI":"10.3109\/00365513.2016.1155230","article-title":"Myocardial dysfunction and cardiovascular disease in type 2 diabetes","volume":"76","author":"Ofstad","year":"2016","journal-title":"Scand J Clin Lab Invest"},{"issue":"8","key":"10.1016\/j.diabres.2021.108959_b0265","doi-asserted-by":"crossref","first-page":"e0161201","DOI":"10.1371\/journal.pone.0161201","article-title":"Hyperglycemia determines increased specific MicroRNAs levels in sera and HDL of acute coronary syndrome patients and stimulates MicroRNAs production in human macrophages","volume":"11","author":"Simionescu","year":"2016","journal-title":"PLoS ONE"},{"issue":"12","key":"10.1016\/j.diabres.2021.108959_b0270","doi-asserted-by":"crossref","first-page":"2554","DOI":"10.2337\/db17-1434","article-title":"miRNA regulation of the hyperproliferative phenotype of vascular smooth muscle cells in diabetes","volume":"67","author":"Torella","year":"2018","journal-title":"Diabetes"},{"issue":"5","key":"10.1016\/j.diabres.2021.108959_b0275","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1172\/JCI200417867","article-title":"Diabetes and diabetes-associated lipid abnormalities have distinct effects on initiation and progression of atherosclerotic lesions","volume":"114","author":"Renard","year":"2004","journal-title":"J Clin Investig"},{"issue":"1","key":"10.1016\/j.diabres.2021.108959_b0280","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1111\/j.1540-8159.2006.00298.x","article-title":"Suboptimal glycemic control, independently of QT interval duration, is associated with increased risk of ventricular arrhythmias in a high-risk population","volume":"29","author":"Chen-Scarabelli","year":"2006","journal-title":"Pacing Clin. Electrophysiology: PACE"},{"issue":"7471","key":"10.1016\/j.diabres.2021.108959_b0285","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1038\/nature12537","article-title":"Diabetic hyperglycaemia activates CaMKII and arrhythmias by O-linked glycosylation","volume":"502","author":"Erickson","year":"2013","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.diabres.2021.108959_b0290","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1161\/CIRCULATIONAHA.106.634949","article-title":"Diabetic cardiovascular autonomic neuropathy","volume":"115","author":"Vinik","year":"2007","journal-title":"Circulation"},{"issue":"4","key":"10.1016\/j.diabres.2021.108959_b0295","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.jchf.2015.10.007","article-title":"Myocardial microvascular inflammatory endothelial activation in heart failure with preserved ejection fraction","volume":"4","author":"Franssen","year":"2016","journal-title":"JACC Heart Fail"},{"issue":"1","key":"10.1016\/j.diabres.2021.108959_b0300","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jchf.2017.07.012","article-title":"Distinct Myocardial Targets for Diabetes Therapy in Heart Failure With Preserved or Reduced Ejection Fraction","volume":"6","author":"Paulus","year":"2018","journal-title":"JACC. Heart failure"},{"issue":"7","key":"10.1016\/j.diabres.2021.108959_b0305","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1002\/ejhf.1790","article-title":"Hyperglycaemia, ejection fraction and the risk of heart failure or cardiovascular death in patients with type 2 diabetes and a recent acute coronary syndrome","volume":"22","author":"Shin","year":"2020","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.diabres.2021.108959_b0310","doi-asserted-by":"crossref","unstructured":"American Diabetes Association (2021). 15. Diabetes Care in the Hospital:Standards of Medical Care in Diabetes-2021.Diabetes care,44(Suppl 1), S211\u2013S220. https:\/\/doi.org\/10.2337\/dc21-S015.","DOI":"10.2337\/dc21-S015"},{"key":"10.1016\/j.diabres.2021.108959_b0315","doi-asserted-by":"crossref","unstructured":"Dungan, K.M., Braithwaite, S.S., Preiser, J.C. Stress hyperglycaemia. Lancet. 2009 May;373(9677):1798\u20131807. https:\/\/doi. org\/10.1016\/S0140-6736(09)60553-5.","DOI":"10.1016\/S0140-6736(09)60553-5"},{"issue":"1","key":"10.1016\/j.diabres.2021.108959_b0320","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/S0749-0704(05)70154-8","article-title":"Stress-induced hyperglycemia","volume":"17","author":"McCowen","year":"2001","journal-title":"Crit Care Clin"},{"issue":"6","key":"10.1016\/j.diabres.2021.108959_b0325","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1186\/cc9256","article-title":"Year in review 2009: Critical Care\u2013metabolism","volume":"14","author":"Huberlant","year":"2010","journal-title":"Critical care (London, England)"},{"key":"10.1016\/j.diabres.2021.108959_b0330","doi-asserted-by":"crossref","unstructured":"Senthinathan, A., Kelly, V., Dzingina, M., Jones, D., Baker, M., Longson, D., & Guideline Development Group (2011). Hyperglycaemia in acute coronary syndromes: summary of NICE guidance.BMJ (Clinical research ed.),343, d6646. https:\/\/doi.org\/10.1136\/bmj.d6646.","DOI":"10.1136\/bmj.d6646"},{"issue":"4","key":"10.1016\/j.diabres.2021.108959_b0335","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1093\/eurheartj\/ehi049","article-title":"Acute hyperglycaemia: a 'new' risk factor during myocardial infarction","volume":"26","author":"Ceriello","year":"2005","journal-title":"Eur Heart J"},{"issue":"7","key":"10.1016\/j.diabres.2021.108959_b0340","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1093\/eurheartj\/ehm010","article-title":"Synergistic relationship between hyperglycaemia and inflammation with respect to clinical outcomes in non-ST-elevation acute coronary syndromes: analyses from OPUS-TIMI 16 and TACTICS-TIMI 18","volume":"28","author":"Ray","year":"2007","journal-title":"Eur Heart J"},{"issue":"11","key":"10.1016\/j.diabres.2021.108959_b0345","doi-asserted-by":"crossref","first-page":"3129","DOI":"10.2337\/diacare.26.11.3129","article-title":"Effects of stress hyperglycemia on acute myocardial infarction: role of inflammatory immune process in functional cardiac outcome","volume":"26","author":"Marfella","year":"2003","journal-title":"Diabetes Care"},{"issue":"12","key":"10.1016\/j.diabres.2021.108959_b0350","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1161\/01.RES.0000130526.20854.fa","article-title":"Inflammatory cytokines and postmyocardial infarction remodeling","volume":"94","author":"Nian","year":"2004","journal-title":"Circ Res"},{"key":"10.1016\/j.diabres.2021.108959_b0355","doi-asserted-by":"crossref","unstructured":"B\u00e4cklund, T., Palojoki, E., Saraste, A., Eriksson, A., Finckenberg, P., Kyt\u00f6, V., Lakkisto, P., Mervaala, E., Voipio-Pulkki, L. M., Laine, M., & Tikkanen, I. (2004). Sustained cardiomyocyte apoptosis and left ventricular remodelling after myocardial infarction in experimental diabetes.Diabetologia,47(2), 325\u2013330. https:\/\/doi.org\/10.1007\/s00125-003-1311-5.","DOI":"10.1007\/s00125-003-1311-5"},{"issue":"3","key":"10.1016\/j.diabres.2021.108959_b0360","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.diabres.2011.09.027","article-title":"The effect of intensive risk factor management in type 2 diabetes on inflammatory biomarkers","volume":"95","author":"Samaropoulos","year":"2012","journal-title":"Diabetes Res Clin Pract"},{"issue":"6","key":"10.1016\/j.diabres.2021.108959_b0365","doi-asserted-by":"crossref","first-page":"1938","DOI":"10.2337\/diabetes.51.6.1938","article-title":"Hyperglycemia-induced apoptosis in mouse myocardium: mitochondrial cytochrome C-mediated caspase-3 activation pathway","volume":"51","author":"Cai","year":"2002","journal-title":"Diabetes"},{"issue":"32","key":"10.1016\/j.diabres.2021.108959_b0370","doi-asserted-by":"crossref","first-page":"5695","DOI":"10.2174\/1381612811319320005","article-title":"Hyperglycemia-induced oxidative stress and its role in diabetes mellitus related cardiovascular diseases","volume":"19","author":"Fiorentino","year":"2013","journal-title":"Curr Pharm Des"},{"issue":"21","key":"10.1016\/j.diabres.2021.108959_b0375","first-page":"3993","article-title":"Effect of anti-oxidant agents in patients with hepatocellular diseases","volume":"19","author":"Di Francia","year":"2015","journal-title":"Eur Rev Med Pharmacol Sci"},{"issue":"2","key":"10.1016\/j.diabres.2021.108959_b0380","first-page":"270","article-title":"Mechanisms of non-alcoholic fatty liver disease in the metabolic syndrome a narrative review","volume":"10","author":"Rinaldi","year":"2021","journal-title":"Antioxidants (Basel, Switzerland)"},{"issue":"8","key":"10.1016\/j.diabres.2021.108959_b0385","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1111\/j.1538-7836.2004.00836.x","article-title":"Platelet activation in type 2 diabetes mellitus","volume":"2","author":"Ferroni","year":"2004","journal-title":"J Thrombosis Haemostasis : JTH"},{"issue":"13\u201314","key":"10.1016\/j.diabres.2021.108959_b0390","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/j.lfs.2011.07.021","article-title":"Relationship of methylglyoxal-adduct biogenesis to LDL and triglyceride levels in diabetics","volume":"89","author":"Turk","year":"2011","journal-title":"Life Sci"},{"issue":"1","key":"10.1016\/j.diabres.2021.108959_b0395","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.cyto.2012.06.018","article-title":"Monocyte chemoattractant Protein 1 (MCP-1) in obesity and diabetes","volume":"60","author":"Panee","year":"2012","journal-title":"Cytokine"},{"issue":"2","key":"10.1016\/j.diabres.2021.108959_b0400","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1186\/cc12514","article-title":"Stress hyperglycemia: an essential survival response!","volume":"17","author":"Marik","year":"2013","journal-title":"Crit. Care."},{"key":"10.1016\/j.diabres.2021.108959_b0405","doi-asserted-by":"crossref","unstructured":"Kajbaf, F., Mojtahedzadeh, M., Abdollahi, M. Mechanisms underlying stress-induced hyperglycemia in critically ill patients. Therapy. 2007 Jan;4(1):97\u2013106. https:\/\/doi.org\/10.2217\/14750708.4.1.97.","DOI":"10.2217\/14750708.4.1.97"},{"issue":"11","key":"10.1016\/j.diabres.2021.108959_b0410","doi-asserted-by":"crossref","first-page":"634","DOI":"10.12968\/hmed.2018.79.11.634","article-title":"Stress-induced hyperglycaemia","volume":"79","author":"Mifsud","year":"2018","journal-title":"Br. J. Hosp. Med. (Lond)"},{"issue":"7","key":"10.1016\/j.diabres.2021.108959_b0415","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1093\/bja\/41.7.588","article-title":"Some effects of anaesthesia and surgery on carbohydrate and fat metabolism","volume":"41","author":"Allison","year":"1969","journal-title":"Br J Anaesth"},{"issue":"4","key":"10.1016\/j.diabres.2021.108959_b0420","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1093\/bja\/42.4.295","article-title":"The influence of anaesthesia and surgery on plasma cortisol, insulin and free fatty acids","volume":"42","author":"Clarke","year":"1970","journal-title":"Br J Anaesth"},{"issue":"2","key":"10.1016\/j.diabres.2021.108959_b0425","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.ijcard.2010.07.019","article-title":"Free fatty acids induce endothelial dysfunction and activate protein kinase C and nuclear factor-\u03baB pathway in rat aorta","volume":"152","author":"Li","year":"2011","journal-title":"Int J Cardiol"},{"issue":"3","key":"10.1016\/j.diabres.2021.108959_b0430","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1530\/JME-11-0082","article-title":"Chronic exposure to high fatty acids impedes receptor agonist-induced nitric oxide production and increments of cytosolic Ca2+ levels in endothelial cells","volume":"47","author":"Tang","year":"2011","journal-title":"J Mol Endocrinol"},{"issue":"5","key":"10.1016\/j.diabres.2021.108959_b0435","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1006\/cyto.1998.0442","article-title":"Interactions of noradrenalin and tumour necrosis factor alpha, interleukin 4 and interleukin 6 in the control of lipolysis from adipocytes around lymph nodes","volume":"11","author":"Mattacks","year":"1999","journal-title":"Cytokine"},{"issue":"3","key":"10.1016\/j.diabres.2021.108959_b0440","doi-asserted-by":"crossref","first-page":"E693","DOI":"10.1152\/ajpendo.00423.2006","article-title":"Mechanism of insulin-stimulated clearance of plasma nonesterified fatty acids in humans","volume":"292","author":"Carpentier","year":"2007","journal-title":"Am J Physio Endocrinol Metab"},{"issue":"2020","key":"10.1016\/j.diabres.2021.108959_b0445","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/B978-0-12-814833-4.00003-4","article-title":"Pathophysiology of diabetes","volume":"1","author":"Tesauro","year":"2020","journal-title":"Transplantation, Bioengineering, and Regeneration of the Endocrine Pancreas"},{"issue":"4","key":"10.1016\/j.diabres.2021.108959_b0450","doi-asserted-by":"crossref","first-page":"H587","DOI":"10.1152\/ajpheart.00894.2013","article-title":"PKC-mediated toxicity of elevated glucose concentration on cardiomyocyte function","volume":"307","author":"Sims","year":"2014","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"1","key":"10.1016\/j.diabres.2021.108959_b0455","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1111\/j.1464-5491.2007.02322.x","article-title":"Acute hyperglycaemia disturbs cardiac repolarization in Type 1 diabetes","volume":"25","author":"Gordin","year":"2008","journal-title":"Diabet Med"},{"key":"10.1016\/j.diabres.2021.108959_b0460","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1113\/jphysiol.2006.114009","article-title":"Glucose reduces endothelin inhibition of voltage-gated potassium channels in rat arterial smooth muscle cells","volume":"575","author":"Rainbow","year":"2006","journal-title":"J Physiol"},{"issue":"3","key":"10.1016\/j.diabres.2021.108959_b0465","doi-asserted-by":"crossref","first-page":"C788","DOI":"10.1152\/ajpcell.00148.2009","article-title":"Regulation of intracerebral arteriolar tone by K(v) channels: effects of glucose and PKC","volume":"297","author":"Straub","year":"2009","journal-title":"Am J Physiol Cell Physiol"},{"key":"10.1016\/j.diabres.2021.108959_b0470","unstructured":"Dhatariya, K., Corsino, L., & Umpierrez, G. E. (2020). Management of Diabetes and Hyperglycemia in Hospitalized Patients. In K. R. Feingold (Eds.) et. al.,Endotext. MDText.com, Inc. South Dartmouth (MA), PMID: 25905318."},{"issue":"6","key":"10.1016\/j.diabres.2021.108959_b0475","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1002\/dmrr.634","article-title":"Insulin resistance and endothelial dysfunction: the road map to cardiovascular diseases","volume":"22","author":"Cersosimo","year":"2006","journal-title":"Diabetes Metab Res Rev"},{"issue":"Suppl 3","key":"10.1016\/j.diabres.2021.108959_b0480","doi-asserted-by":"crossref","first-page":"S47","DOI":"10.2337\/diab.45.3.S47","article-title":"Effects of insulin and IGF-I on vascular smooth muscle glucose and cation metabolism","volume":"45","author":"Sowers","year":"1996","journal-title":"Diabetes"},{"issue":"3\u20104","key":"10.1016\/j.diabres.2021.108959_b0485","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1111\/j.1440-1681.1998.t01-15-.x","article-title":"Insulin as a vascular hormone: implications for the pathophysiology of cardiovascular disease","volume":"25","author":"Cleland","year":"1998","journal-title":"Clin Exp Pharmacol Physiol"},{"issue":"3","key":"10.1016\/j.diabres.2021.108959_b0490","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1097\/00005344-199909000-00009","article-title":"The role of adenosine in insulin-induced vasodilation","volume":"34","author":"Abbink-Zandbergen","year":"1999","journal-title":"J. Cardiovasc Pharmacol"},{"issue":"12","key":"10.1016\/j.diabres.2021.108959_b0495","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1046\/j.1365-2362.2000.00749.x","article-title":"Insulin-mediated increases in renal plasma flow are impaired in insulin-resistant normal subjects","volume":"30","author":"Ter Maaten","year":"2000","journal-title":"Eur J Clin Invest"},{"issue":"6","key":"10.1016\/j.diabres.2021.108959_b0500","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1042\/CS20140404","article-title":"Fatty acids and the risk of death during acute myocardial ischaemia","volume":"128","author":"Oliver","year":"2015","journal-title":"Clin Sci (Lond)"},{"issue":"4","key":"10.1016\/j.diabres.2021.108959_b0505","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1001\/jama.293.4.437","article-title":"CREATE-ECLA Trial Group Investigators. Effect of glucose-insulin-potassium infusion on mortality in patients with acute ST-segment elevation myocardial infarction: the CREATE-ECLA randomized controlled trial","volume":"293","author":"Mehta","year":"2005","journal-title":"JAMA"},{"key":"10.1016\/j.diabres.2021.108959_b0510","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.phrs.2017.07.020","article-title":"The epicardium as a source of multipotent adult cardiac progenitor cells: Their origin, role and fate","volume":"127","author":"Smits","year":"2018","journal-title":"Pharmacol Res"},{"issue":"6","key":"10.1016\/j.diabres.2021.108959_b0515","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1016\/S0092-8674(03)00687-1","article-title":"Adult cardiac stem cells are multipotent and support myocardial regeneration","volume":"114","author":"Beltrami","year":"2003","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.diabres.2021.108959_b0520","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1161\/01.RES.0000231289.63468.08","article-title":"Diabetes promotes cardiac stem cell aging and heart failure, which are prevented by deletion of the p66shc gene","volume":"99","author":"Rota","year":"2006","journal-title":"Circ Res"},{"key":"10.1016\/j.diabres.2021.108959_b0525","doi-asserted-by":"crossref","unstructured":"Marfella, R., Sasso, F.C., Cacciapuoti, F., Portoghese, M., Rizzo, M.R., Siniscalchi, M., Carbonara, O., Ferraraccio, F., Torella, M., Petrella, A., Balestrieri, M.L., Stiuso, P., Nappi, G., Paolisso, G. Tight glycemic control may increase regenerative potential of myocardium during acute infarction. J Clin Endocrinol Metab 2012 Mar;97(3):933\u201342. doi: 10.1210\/jc.2011-2037.","DOI":"10.1210\/jc.2011-2037"},{"issue":"1","key":"10.1016\/j.diabres.2021.108959_b0530","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/S1056-8727(98)00019-1","article-title":"Hyperglycemia without hyperinsulinemia produces both sympathetic neural activation and vasodilation in normal humans","volume":"13","author":"Hoffman","year":"1999","journal-title":"J Diabetes Complications"},{"issue":"5","key":"10.1016\/j.diabres.2021.108959_b0535","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1291\/hypres.31.1033","article-title":"Acute hyperglycemia and hyperinsulinemia enhance adrenergic vasoconstriction and decrease calcitonin gene-related peptide-containing nerve-mediated vasodilation in pithed rats","volume":"31","author":"ZAMAMI","year":"2008","journal-title":"Hypertens Res"},{"issue":"1","key":"10.1016\/j.diabres.2021.108959_b0540","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1038\/s41572-020-0151-7","article-title":"Acute heart failure","volume":"6","author":"Arrigo","year":"2020","journal-title":"Nat Rev Dis Primers"},{"issue":"23","key":"10.1016\/j.diabres.2021.108959_b0545","doi-asserted-by":"crossref","first-page":"3078","DOI":"10.1161\/CIRCULATIONAHA.104.517839","article-title":"Admission glucose and mortality in elderly patients hospitalized with acute myocardial infarction: implications for patients with and without recognized diabetes","volume":"111","author":"Kosiborod","year":"2005","journal-title":"Circulation"},{"issue":"2","key":"10.1016\/j.diabres.2021.108959_b0550","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1177\/0003319713488930","article-title":"Admission hyperglycemia predicts inhospital mortality and major adverse cardiac events after primary percutaneous coronary intervention in patients without diabetes mellitus","volume":"65","author":"Ekmekci","year":"2014","journal-title":"Angiology"},{"issue":"4","key":"10.1016\/j.diabres.2021.108959_b0555","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1093\/ehjcvp\/pvv023","article-title":"Meta-analysis of admission hyperglycaemia in acute myocardial infarction patients treated with primary angioplasty: a cause or a marker of mortality?","volume":"1","author":"Singh","year":"2015","journal-title":"Eur Heart J Cardiovas Pharmacother"},{"key":"10.1016\/j.diabres.2021.108959_b0560","doi-asserted-by":"crossref","unstructured":"Cavallari, I., Maddaloni, E., Gragnano, F., Patti, G., Antonucci, E., Calabr\u00f2, P., Cirillo, P., Gresele, P., Palareti, G., Pengo, V., Pignatelli, P., Marcucci, R., & START-ANTIPLATELET collaborators (2021). Ischemic and bleeding risk by type 2 diabetes clusters in patients with acute coronary syndrome.Internal and emergency medicine, 10.1007\/s11739-021-02640-z. Advance online publication. https:\/\/doi.org\/10.1007\/s11739-021-02640-z.","DOI":"10.1007\/s11739-021-02640-z"},{"issue":"5","key":"10.1016\/j.diabres.2021.108959_b0565","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1177\/1479164119845612","article-title":"Glucose-lowering therapy and cardiovascular outcomes in patients with type 2 diabetes mellitus and acute coronary syndrome","volume":"16","author":"Avogaro","year":"2019","journal-title":"Diabetes Vasc Dis Res"},{"issue":"1","key":"10.1016\/j.diabres.2021.108959_b0570","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/0735-1097(95)00126-K","article-title":"Randomized trial of insulin-glucose infusion followed by subcutaneous insulin treatment in diabetic patients with acute myocardial infarction (DIGAMI study): effects on mortality at 1 year","volume":"26","author":"Malmberg","year":"1995","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.diabres.2021.108959_b0575","doi-asserted-by":"crossref","unstructured":"Malmberg, K., Ryd\u00e9n, L., Wedel, H., Birkeland, K., Bootsma, A., Dickstein, K., Efendic, S., Fisher, M., Hamsten, A., Herlitz, J., Hildebrandt, P., MacLeod, K., Laakso, M., Torp-Pedersen, C., Waldenstr\u00f6m, A., & DIGAMI 2 Investigators (2005). Intense metabolic control by means of insulin in patients with diabetes mellitus and acute myocardial infarction (DIGAMI 2): effects on mortality and morbidity.Eur Heart J 26(7), 650\u2013661. https:\/\/doi.org\/10.1093\/eurheartj\/ehi199.","DOI":"10.1093\/eurheartj\/ehi199"},{"issue":"6","key":"10.1016\/j.diabres.2021.108959_b0580","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1161\/01.CIR.45.6.1160","article-title":"Effect of glucose-insulin-potassium infusion on myocardial infarction following experimental coronary artery occlusion","volume":"45","author":"Maroko","year":"1972","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.diabres.2021.108959_b0585","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1161\/01.CIR.52.1.49","article-title":"Effects of glucose, insulin and potassium infusion on tissue metabolic changes within first hour of myocardial infarction in the baboon","volume":"52","author":"Opie","year":"1975","journal-title":"Circulation"},{"issue":"4","key":"10.1016\/j.diabres.2021.108959_b0590","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1161\/01.CIR.96.4.1152","article-title":"Glucose-insulin-potassium therapy for treatment of acute myocardial infarction: an overview of randomized placebo-controlled trials","volume":"96","author":"Fath-Ordoubadi","year":"1997","journal-title":"Circulation"},{"key":"10.1016\/j.diabres.2021.108959_b0595","doi-asserted-by":"crossref","unstructured":"Mellbin, L. G., Malmberg, K., Norhammar, A., Wedel, H., Ryd\u00e9n, L., & DIGAMI 2 Investigators (2008). The impact of glucose lowering treatment on long-term prognosis in patients with type 2 diabetes and myocardial infarction: a report from the DIGAMI 2 trial.European heart journal,29(2), 166\u2013176. https:\/\/doi.org\/10.1093\/eurheartj\/ehm518.","DOI":"10.1093\/eurheartj\/ehm518"},{"issue":"4","key":"10.1016\/j.diabres.2021.108959_b0600","doi-asserted-by":"crossref","first-page":"765","DOI":"10.2337\/diacare.29.04.06.dc05-1894","article-title":"The Hyperglycemia: Intensive Insulin Infusion in Infarction (HI-5) study: a randomized controlled trial of insulin infusion therapy for myocardial infarction","volume":"29","author":"Cheung","year":"2006","journal-title":"Diabetes Care"},{"issue":"5","key":"10.1016\/j.diabres.2021.108959_b0605","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1016\/S0735-1097(03)00830-1","article-title":"Glucose-insulin-potassium infusion inpatients treated with primary angioplasty for acute myocardial infarction: the glucose-insulin-potassium study: a randomized trial","volume":"42","author":"van der Horst","year":"2003","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.diabres.2021.108959_b0610","doi-asserted-by":"crossref","unstructured":"Mehta, S. R., Yusuf, S., D\u00edaz, R., Zhu, J., Pais, P., Xavier, D., Paolasso, E., Ahmed, R., Xie, C., Kazmi, K., Tai, J., Orlandini, A., Pogue, J., Liu, L., & CREATE-ECLA Trial Group Investigators. Effect of glucose-insulin-potassium infusion on mortality in patients with acute ST-segment elevation myocardial infarction: the CREATE-ECLA randomized controlled trial. JAMA, 293(4) (2005).437\u2013446. https:\/\/doi.org\/10.1001\/jama.293.4.437","DOI":"10.1001\/jama.293.4.437"},{"key":"10.1016\/j.diabres.2021.108959_b0615","doi-asserted-by":"crossref","unstructured":"NICE-SUGAR Study Investigators, Finfer, S., Chittock, D. R., Su, S. Y., Blair, D., Foster, D., Dhingra, V., Bellomo, R., Cook, D., Dodek, P., Henderson, W. R., H\u00e9bert, P. C., Heritier, S., Heyland, D. K., McArthur, C., McDonald, E., Mitchell, I., Myburgh, J. A., Norton, R., Potter, J., \u2026 Ronco, J. J. (2009). Intensive versus conventional glucose control in critically ill patients. The New England J Med, 360(13), 1283\u20131297. https:\/\/doi.org\/10.1056\/NEJMoa0810625.","DOI":"10.1056\/NEJMoa0810625"},{"issue":"3","key":"10.1016\/j.diabres.2021.108959_b0620","first-page":"395","article-title":"Defining aging phenotypes and related outcomes: clues to recognize frailty in hospitalized older patients","volume":"72","author":"Marcucci","year":"2017","journal-title":"J Gerontol Series A, Biol Sci Med Sci"},{"issue":"7","key":"10.1016\/j.diabres.2021.108959_b0625","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/j.ejim.2014.06.027","article-title":"Gender-differences in disease distribution and outcome in hospitalized elderly: data from the REPOSI study","volume":"25","author":"Corrao","year":"2014","journal-title":"Eur J Internal Med"},{"key":"10.1016\/j.diabres.2021.108959_b0630","doi-asserted-by":"crossref","unstructured":"Collet JP, Thiele H, Barbato E, et al. 2020 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation [published correction appears in Eur Heart J. 2021 May 14;42(19):1908] [published correction appears in Eur Heart J. 2021 May 14;42(19):1925] [published correction appears in Eur Heart J. 2021 May 13;:].Eur Heart J. 2021;42(14):1289\u20131367. doi:10.1093\/eurheartj\/ehaa575.","DOI":"10.1093\/eurheartj\/ehab088"},{"key":"10.1016\/j.diabres.2021.108959_b0635","doi-asserted-by":"crossref","unstructured":"Ibanez B, James S, Agewall S, et al. 2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: The Task Force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European Society of Cardiology (ESC).Eur Heart J. 2018;39(2):119\u2013177. doi:10.1093\/eurheartj\/ehx393.","DOI":"10.1093\/eurheartj\/ehx393"},{"key":"10.1016\/j.diabres.2021.108959_b0640","unstructured":"From the American Association of Neurological Surgeons (AANS), American Society of Neuroradiology (ASNR), Cardiovascular and Interventional Radiology Society of Europe (CIRSE), Canadian Interventional Radiology Association (CIRA), Congress of Neurological Surgeons (CNS), European Society of Minimally Invasive Neurological Therapy (ESMINT), European Society of Neuroradiology (ESNR), European Stroke Organization (ESO), Society for Cardiovascular Angiography and Interventions (SCAI), Society of Interventional Radiology (SIR), Society of NeuroInterventional Surgery (SNIS), and World Stroke Organization (WSO), Sacks D, Baxter B, et al. Multisociety Consensus Quality Improvement Revised Consensus Statement for Endovascular Therapy of Acute Ischemic Stroke.Int J Stroke. 2018;13(6):612-632. doi:10.1177\/1747493018778713."},{"key":"10.1016\/j.diabres.2021.108959_b0645","doi-asserted-by":"crossref","unstructured":"Senthinathan A, Kelly V, Dzingina M, et al. Hyperglycaemia in acute coronary syndromes: summary of NICE guidance.BMJ. 2011;343:d6646. Published 2011 Oct 26. doi:10.1136\/bmj.d6646.","DOI":"10.1136\/bmj.d6646"},{"key":"10.1016\/j.diabres.2021.108959_b0650","doi-asserted-by":"crossref","unstructured":"American Diabetes Association. 10. Cardiovascular Disease and Risk Management:Standards of Medical Care in Diabetes-2021[published correction appears in Diabetes Care. 2021 Jun 16;:].Diabetes Care. 2021;44(Suppl 1):S125\u2013S150. doi:10.2337\/dc21-S010.","DOI":"10.2337\/dc21-S010"},{"issue":"2","key":"10.1016\/j.diabres.2021.108959_b0655","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1111\/dom.13881","article-title":"Primary versus secondary cardiorenal prevention in type 2 diabetes: Which newer anti-hyperglycaemic drug matters?","volume":"22","author":"Giugliano","year":"2020","journal-title":"Diabetes Obes Metab."},{"key":"10.1016\/j.diabres.2021.108959_b0660","article-title":"Effects of canagliflozin on myocardial infarction: a post hoc analysis of the CANVAS Program and CREDENCE trial [published online ahead of print, 2021 Apr 7]","author":"Yu","year":"2021128","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.diabres.2021.108959_b0665","doi-asserted-by":"crossref","first-page":"109504","DOI":"10.1016\/j.mehy.2019.109504","article-title":"GLP 1 receptor agonists, glycemic variability, oxidative stress and acute coronary syndrome","volume":"136","author":"del Olmo Garc\u00eda","year":"2020","journal-title":"Med Hypotheses."},{"key":"10.1016\/j.diabres.2021.108959_b0670","doi-asserted-by":"crossref","unstructured":"Trevisan M, Fu EL, Szummer K, et al. Glucagon-like peptide-1 receptor agonists and the risk of cardiovascular events in diabetes patients surviving an acute myocardial infarction. Eur Heart J Cardiovasc Pharmacother 2021;7(2):104\u2013111. doi:10.1093\/ehjcvp\/pvaa004.","DOI":"10.1093\/ehjcvp\/pvaa004"},{"key":"10.1016\/j.diabres.2021.108959_b0675","doi-asserted-by":"crossref","unstructured":"Kahles F, R\u00fcckbeil MV, Mertens RW, et al. Glucagon-like peptide 1 levels predict cardiovascular risk in patients with acute myocardial infarction. Eur Heart J 2020;41(7):882\u2013889. doi:10.1093\/eurheartj\/ehz728.","DOI":"10.1093\/eurheartj\/ehz728"},{"key":"10.1016\/j.diabres.2021.108959_b0680","doi-asserted-by":"crossref","unstructured":"Roos ST, Timmers L, Biesbroek PS, et al. No benefit of additional treatment with exenatide in patients with an acute myocardial infarction. Int J Cardiol 2016;220:809\u2013814. doi:10.1016\/j.ijcard.2016.06.283.","DOI":"10.1016\/j.ijcard.2016.06.283"}],"container-title":["Diabetes Research and Clinical Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168822721003181?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168822721003181?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T19:20:06Z","timestamp":1759173606000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168822721003181"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8]]},"references-count":136,"alternative-id":["S0168822721003181"],"URL":"https:\/\/doi.org\/10.1016\/j.diabres.2021.108959","relation":{},"ISSN":["0168-8227"],"issn-type":[{"value":"0168-8227","type":"print"}],"subject":[],"published":{"date-parts":[[2021,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Does a strict glycemic control during acute coronary syndrome play a cardioprotective effect? Pathophysiology and clinical evidence","name":"articletitle","label":"Article Title"},{"value":"Diabetes Research and Clinical Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.diabres.2021.108959","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"108959"}}